Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages

被引:66
作者
Antoniv, Taras T.
Ivashkiv, Lionel B.
机构
[1] Hosp Special Surg, Dept Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, New York, NY USA
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词
D O I
10.1002/art.22055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The inflammatory cytokines tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) are produced by activated macrophages, are key mediators of pathogenesis, and are validated therapeutic targets in rheumatoid arthritis (RA) and seronegative spondylarthritis (SpA). IL-10 is a potent antfinflammatory cytokine that suppresses macrophage TNF alpha and IL-1 production, yet is not effective in suppressing inflammatory arthritis. To gain insight into IL-10 responses in inflammatory arthritis, we used microarray analysis to determine the patterns of IL-10-inducible gene expression in freshly isolated RA and seronegative SpA synovial macrophages. Methods. Macrophages from the synovial fluid of 5 patients with RA and 3 with seronegative SpA (2 with psoriatic arthritis and 1 with ankylosing spondylitis) were isolated by positive selection and stimulated ex vivo with IL-10 or interferon-gamma (IFN gamma). Gene expression was analyzed using Affymetrix microarrays and protocols. Real-time polymerase chain reaction was used to confirm changes in gene expression. Results. The number of genes induced by IL-10 in arthritic macrophages was markedly smaller than that induced in control macrophages, and the strength of induction was lower in arthritic macrophages for most genes. The residual response of arthritic macrophages to IL-10 stimulation was qualitatively altered, such that IL-10 preferentially increased expression of IFN gamma-inducible genes. In contrast, arthritic macrophages expressed many IFN gamma-inducible genes prior to stimulation, and their response to IFN gamma remained mostly intact. Conclusion. These results demonstrate that IL-10 responses are dysregulated in RA synovial macrophages. An altered biologic response to IL-10, with attenuation of its antfinflammatory function and a concomitant retention of IFN gamma-like activating functions, provides a basis for the lack of efficacy of IL-10 in suppressing inflammatory arthritis.
引用
收藏
页码:2711 / 2721
页数:11
相关论文
共 44 条
[1]   Pathogenesis of psoriatic arthritis [J].
Anandarajah, AP ;
Ritchlin, CT .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (04) :338-343
[2]   Kinetics of IL-10-induced gene expression in human macrophages [J].
Antoniv, TT ;
Park-Min, KH ;
Ivashkiv, LB .
IMMUNOBIOLOGY, 2005, 210 (2-4) :87-95
[3]  
ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
[4]  
Avdiushko R, 2001, J LEUKOCYTE BIOL, V70, P624
[5]   INTERLEUKIN-10 ADMINISTRATION DECREASES SURVIVAL IN MURINE RECIPIENTS OF MAJOR HISTOCOMPATIBILITY COMPLEX DISPARATE DONOR BONE-MARROW GRAFTS [J].
BLAZAR, BR ;
TAYLOR, PA ;
SMITH, S ;
VALLERA, DA .
BLOOD, 1995, 85 (03) :842-851
[6]   IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE) [J].
Bussolati, B ;
Rollino, C ;
Mariano, F ;
Quarello, F ;
Camussi, G .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (03) :471-476
[7]   SOCS3 negatively regulates IL-6 signaling in vivo [J].
Croker, BA ;
Krebs, DL ;
Zhang, JG ;
Wormald, S ;
Willson, TA ;
Stanley, EG ;
Robb, L ;
Greenhalgh, CJ ;
Förster, I ;
Clausen, BE ;
Nicola, NA ;
Metcalf, D ;
Hilton, DJ ;
Roberts, AW ;
Alexander, WS .
NATURE IMMUNOLOGY, 2003, 4 (06) :540-545
[8]   Microarray analysis of gene expression in lupus [J].
Crow, MK ;
Wohlgemuth, J .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (06) :279-287
[9]   Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis:: Signaling roles of nitric oxide synthase-2 and phagocyte oxidase [J].
Ehrt, S ;
Schnappinger, D ;
Bekiranov, S ;
Drenkow, J ;
Shi, SP ;
Gingeras, TR ;
Gaasterland, T ;
Schoolnik, G ;
Nathan, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (08) :1123-1139
[10]   Anti-TNFα therapy of rheumatoid arthritis:: what have we learned? [J].
Feldmann, M ;
Maini, RN .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :163-196